These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39012629)

  • 1. Human Papillomavirus Vaccination by Birth Fiscal Year in Japan.
    Yagi A; Ueda Y; Oka E; Nakagawa S; Kimura T
    JAMA Netw Open; 2024 Jul; 7(7):e2422513. PubMed ID: 39012629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Even though active recommendation for HPV vaccination has restarted, Japan's rates have not recovered.
    Yagi A; Ueda Y; Oka E; Nakagawa S; Kimura T; Shimoya K
    Cancer Sci; 2024 Jul; 115(7):2410-2416. PubMed ID: 38698561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of catch-up and routine program of the 9-valent vaccine on cervical cancer risk reduction in Japan.
    Yagi A; Nakagawa S; Ueda Y; Oka E; Ikeda S; Kakuda M; Kobayashi E; Ito Y; Katayama K; Hirai K; Nakayama T; Kimura T
    Cancer Sci; 2024 Mar; 115(3):916-925. PubMed ID: 38158850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan.
    Nakagawa S; Ueda Y; Yagi A; Ikeda S; Hiramatsu K; Kimura T
    Cancer Sci; 2020 Jun; 111(6):2156-2162. PubMed ID: 32248632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation.
    Ishimoto T; Yagi A; Nakajima K; Okamoto N; Yukimitsu E; Kawasaki M; Kawae Y; Hayasaka S; Ueda Y; Kimura T
    Hum Vaccin Immunother; 2023 Aug; 19(2):2229222. PubMed ID: 37462048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation.
    Ueda Y; Yagi A; Abe H; Nakagawa S; Minekawa R; Kuroki H; Miwa A; Kimura T
    Sci Rep; 2020 Sep; 10(1):16091. PubMed ID: 32999408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?
    Yagi A; Ueda Y; Nakagawa S; Ikeda S; Kakuda M; Hiramatsu K; Miyoshi A; Kobayashi E; Kimura T; Mizushima T; Suzuki Y; Sekine M; Hirai K; Nakayama T; Miyagi E; Enomoto T; Kimura T
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age, gender and socioeconomic disparities in human papillomavirus (HPV) awareness and knowledge among Japanese adults after a 7-year suspension of proactive recommendation for the HPV vaccine: A nationally representative cross-sectional survey.
    Terada M; Shimazu T; Saito J; Odawara M; Otsuki A; Yaguchi-Saito A; Miyawaki R; Kuchiba A; Ishikawa H; Fujimori M; Kreps GL;
    Vaccine; 2023 Nov; 41(48):7147-7158. PubMed ID: 37866996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of self-funded human papillomavirus vaccine recipients from Japan's previously assumed "unvaccinated generation".
    Kobayashi M; Nakagawa S; Ueda Y; Yagi A; Kakuda M; Hiramatsu K; Kimura T
    Cancer Sci; 2024 Sep; 115(9):3099-3106. PubMed ID: 38992919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan.
    Yagi A; Ueda Y; Nakagawa S; Masuda T; Miyatake T; Ikeda S; Abe H; Hirai K; Sekine M; Miyagi E; Enomoto T; Nakayama T; Kimura T
    Cancer Sci; 2021 Sep; 112(9):3691-3698. PubMed ID: 34252250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The controversy on HPV vaccination in Japan: Criticism of the ethical validity of the arguments for the suspension of the proactive recommendation.
    Okita T; Enzo A; Kadooka Y; Tanaka M; Asai A
    Health Policy; 2020 Feb; 124(2):199-204. PubMed ID: 31924344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
    Garon J; Wuddhika IV; Sreenivasan N; Wannemuehler K; Vutthikol Y; Chhorvann C; Loharikar A
    Vaccine; 2019 Feb; 37(9):1202-1208. PubMed ID: 30686637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV Vaccine Issues in Japan: A review of our attempts to promote the HPV vaccine and to provide effective evaluation of the problem through social-medical and behavioral-economic perspectives.
    Yagi A; Ueda Y; Kimura T
    Vaccine; 2024 Sep; 42(22):125859. PubMed ID: 38616440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Papillomavirus (HPV) vaccination coverage among French adolescents: A claims data study.
    de Pouvourville G; Guyot E; Farge G; Belhassen M; Bérard M; Jacoud F; Bensimon L; Baldauf JJ
    Vaccine; 2024 Sep; 42(22):126039. PubMed ID: 38852035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.
    Larson HJ; Wilson R; Hanley S; Parys A; Paterson P
    Hum Vaccin Immunother; 2014; 10(9):2543-50. PubMed ID: 25483472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort.
    Sayinzoga F; Umulisa MC; Sibomana H; Tenet V; Baussano I; Clifford GM
    Vaccine; 2020 May; 38(24):4001-4005. PubMed ID: 32336599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of Japanese mothers on the effectiveness of the Ministry of Health, Labor and Welfare's revised HPV vaccine leaflet.
    Shiomi M; Ueda Y; Abe H; Yagi A; Sakiyama K; Kimura T; Tanaka Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Okada H; Nakai H; Matsumura N; Saito J; Takagi T; Horikoshi Y; Shimura K
    Hum Vaccin Immunother; 2020 Oct; 16(10):2555-2558. PubMed ID: 32243236
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study.
    Simms KT; Hanley SJB; Smith MA; Keane A; Canfell K
    Lancet Public Health; 2020 Apr; 5(4):e223-e234. PubMed ID: 32057317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of future cervical cancer risk in Japan, based on birth year.
    Yagi A; Ueda Y; Ikeda S; Sekine M; Nakayama T; Miyagi E; Enomoto T
    Vaccine; 2019 May; 37(22):2889-2891. PubMed ID: 31027925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing trends in HPV vaccination in Japan.
    Ujiie M; Kitano T; Tsuzuki S
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 34619059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.